Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal
The DOI matches its Crossref record.
Abstract
Prolonged glucosamine (GlcN) infusion increases the skeletal muscle hexosamine concentration and induces peripheral insulin resistance in conscious rats. IGF-1 and insulin share common steps in signal transduction, and the action of IGF-1 on carbohydrate metabolism is preserved in certain insulin-resistant states. In our study, we attempted to delineate whether increased GlcN availability also impairs the effects of IGF-1 on glucose uptake (Rd), glycolysis, and glycogen synthesis. We performed euglycemic IGF-1 (5 and 15 μg · kg−1 · min−1) and insulin (3 and 18 mU mg · kg−1 · min−1) clamp studies at 0–2 h and 5–7 h in conscious rats (n = 44) during saline or GlcN infusions. GlcN infusion raised plasma GlcN levels to ∼ 2.0 mmol/l and skeletal muscle uridinediphospho-n-acetylglucosamine to 80–150 nmol/g (approximately three- to fivefold over basal). During physiological hyperinsulinemia (3 mU · kg−1 · min−1, plasma insulin ≌ 50 μU/ml), GlcN infusion caused comparable decreases in Rd (15.7 ± 1.0 [5–7 h] vs. 21.7 ± 2.3 [0–2 h] mg · kg−1 · min−1; P < 0.01) and glycogen synthesis (5.4 ± 0.5 [5–7 h] vs. 10.4 ± 1.9 [0–2 h] mg · kg−1 · min−1; P < 0.005). Furthermore, GlcN markedly decreased Rd by 7.8 ± 1.2 mg · kg−1 · min−1 (18.7 ± 0.7 [5–7 h] vs. 26.5 ± 1.3 [0–2 h] mg · kg−1 · min−1; P < 0.001 vs. control) during IGF-1 (5 μg · kg−1 · min−1) clamp studies. This decline was associated with a 26% decrease in the steady-state concentration of skeletal muscle Glc-6-P (286 ± 45 vs. 386 ± 36 nmol/g; P < 0.01) and was primarily caused by impaired glycogen synthesis (6.7 ± 0.5 [5–7 h] vs. 13.9 ± 0.9 [0–2 h] mg · kg−1 · min−1; P < 0.005). The effects of GlcN infusion on glucose disposal (percentage decrease in Rd) were correlated (r2 = 0.803; P < 0.01) with the skeletal muscle concentration of UDP-GlcNAc. To investigate whether IGF-1 can overcome GlcN-induced insulin resistance, GlcN and insulin (18 mU · kg−1 · min−1) were infused for 7 h during euglycemic clamps, and IGF-1 (15 μg · kg−1 · min−1) was superimposed during the final 2 h. GlcN infusion induced severe impairment of insulin action on Rd (39.4 ± 3.2 [4–5 h] vs. 49.8 ± 3.6 [1–2 h] mg · kg−1 · min−1; P < 0.05), which the addition of IGF-1 failed to improve (35.9 ± 2.3 [6–7 h] vs. 39.4 ± 3.2 [4–5 h] mg · kg−1 · min−1; P > 0.1). In summary, GlcN induced severe resistance to the actions of both insulin and IGF-1 on glucose uptake and glycogen synthesis, and IGF-1 was unable to overcome GlcN-induced insulin resistance. Thus, it is likely that GlcN causes peripheral insulin resistance acting at a site common to both IGF-1 and insulin signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Spiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,409
Interventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
Self-citationThe Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Love, D. C., & Hanover, J. A. (2005) · Science's STKE · doi:10.1126/stke.3122005re13 · Cited by 461
ZACHARA, N. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.016 · Cited by 426
Cell signaling, the essential role of O-GlcNAc
Zachara, N. E., & Hart, G. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.007 · Cited by 386
Metadata
- Authors
- Hawkins, M., Barzilai, N., Chen, W., Angelov, I., Hu, M., Cohen, P., & Rossetti, L.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1996-12-01
- Volume
- 45
- Issue
- 12
- Pages
- 1734-1743
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2155614207
- Cited by
- 46
- References
- 0
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal. https://app.cochat.ai/papers/10.2337/diab.45.12.1734
- The paper
- Hawkins, M., Barzilai, N., Chen, W., Angelov, I., Hu, M., Cohen, P., & Rossetti, L. (1996). Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal. Diabetes. https://doi.org/10.2337/diab.45.12.1734
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.